Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 11:7:1600836.
doi: 10.3389/fdgth.2025.1600836. eCollection 2025.

An evidence-based digital prescription opioid safety toolkit for national dissemination: co-design and user testing

Affiliations

An evidence-based digital prescription opioid safety toolkit for national dissemination: co-design and user testing

Alex Waddell et al. Front Digit Health. .

Abstract

Introduction: Australia has one of the highest rates of opioid prescribing and prescription opioid-related harm in the world. Although effective for pain relief, the use of prescription opioids is a leading cause of preventable morbidity and mortality. Barriers exist for consumers identifying their own risk factors, accessing naloxone (opioid overdose antidote) and overdose prevention education. This study aimed to co-design a digital Opioid Safety Toolkit for national dissemination through pharmacies to encourage three consumer opioid safety behaviours: (1) uptake of naloxone, (2) creating a safety plan, and (3) discussing their use of opioids, including any concerns with their healthcare professional.

Methods: The digital Toolkit was co-designed and developed using a novel approach to digital health intervention design combining the Theoretical Domains Framework (TDF) and Double-Diamond design process. Co-design involved a series of seven iterative workshops with consumers (4) and professionals (3). Workshops focused on identifying factors influencing opioid safety behaviours, exploring design preferences, sense-checking, and ideation of the user flow. User testing was conducted with the penultimate version of the Toolkit.

Results: 13 consumers with lived experience of prescription opioid use and 14 professionals including prescribers, pharmacists, pain specialists, researchers and consumer advocates participated in up to three separate workshops. 15 consumers participated in user testing interviews. Analysis of workshops identified factors promoting safety behaviours including increased public awareness of naloxone, understanding personal risk (TDF domain of Knowledge); healthcare professional's role in education and consumers' experience of stigma (Social/professional role and identity); use of conversational aids to scaffold conversations, material resources and data ownership (Environment, context and resources). User testing elicited feedback pertaining to the information and resources on the website and the overall user interface and experience.

Discussion: The Toolkit was co-designed with consumers and professionals to facilitate opioid safety behaviours. The Toolkit includes evidence-based information, tools for risk assessment and screening, opioid use monitoring, conversation aids, and a safety plan. The Toolkit is being disseminated nationally through Australian pharmacies following a randomized controlled trial that demonstrated the Toolkit promotes safety behaviours, is easy to use and acceptable to those with lived experience of prescription opioid use and professionals.

Keywords: behavioural science; co-design; health literacy; human-computer interaction; implementation science; naloxone; opioids.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The opioid safety toolkit design process as guided by the double diamond process and relevant activities. Adapted with permission from “How to apply a design thinking, HCD, UX or any creative process from scratch” by Dan Nessler.
Figure 2
Figure 2
Opioid safety toolkit webpage “Screenshot from:Opiod Safety Toolkit, https://saferopioiduse.com.au/”.

Similar articles

References

    1. Roxburgh A, Hall WD, Dobbins T, Gisev N, Burns L, Pearson S, et al. Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug Alcohol Depend. (2017) 179:291–8. 10.1016/j.drugalcdep.2017.07.018 - DOI - PubMed
    1. Chrzanowska A, Man N, Akhurst J, Sutherland R, Degenhardt L, Peacock A. Trends in Overdose and Other Drug-Induced Deaths in Australia 2002–2021. Sydney: National Drug and Alcohol Research Centre; UNSW Sydney; (2023).
    1. Health AIo, Welfare. Alcohol, Tobacco & Other Drugs in Australia. Canberra: AIHW; (2024).
    1. Chrzanowska A, Man N, Sutherland R, Degenhardt L, Peacock A. Trends in Overdose and Other Drug-induced Deaths in Australia, 2003-2022. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; (2024). p. 1–4. 10.26190/unsworks/30158 - DOI
    1. Nguyen T, Buxton JA. Pathways between COVID-19 public health responses and increasing overdose risks: a rapid review and conceptual framework. Int J Drug Policy. (2021) 93:103236. 10.1016/j.drugpo.2021.103236 - DOI - PMC - PubMed

LinkOut - more resources